LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas is on the steering committeee of the "Partnering for Global Health Forum 2008" in Washington, DC
News | 03. 10. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.